FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224142777> ?p ?o ?g. }

• W4224142777 abstract "Introduction Juvenile-onset systemic lupus erythematous (JSLE) is a rare multisystem autoimmune disorder. In 2012, the Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) initiative developed recommendations for the diagnosis/management of JSLE, lupus nephritis (LN) and childhood-onset anti-phospholipid syndrome (APS). These recommendations were based upon available evidence informing international expert consensus meetings. Objective To review new evidence published since 2012 relating to the management of JSLE, LN and APS in children, since the original literature searches informing the SHARE recommendations were performed. Method MEDLINE, EMBASE and CINAHL were systematically searched for relevant literature (2012-2021) using the following criteria: (1) English language studies; (2) original research studies regarding management of JSLE, LN, APS in children; (3) adult studies with 3 or more patients &lt;18-years old, or where the lower limit of age range ≤16-years and the mean/median age is ≤30-years; (4) randomized controlled trials (RCTs), cohort studies, case control studies, observational studies, case-series with &gt;3 patients. Three reviewers independently screened all titles/abstracts against predefined inclusion/exclusion criteria. All relevant manuscripts were reviewed independently by at least two reviewers. Data extraction, assessment of the level of evidence/methodological quality of the manuscripts was undertaken in-line with the original SHARE processes. Specific PUBMED literature searches were also performed to identify new evidence relating to each existing SHARE treatment recommendation. Results Six publications met the inclusion/exclusion criteria for JSLE: three RCTs, one feasibility trial, one case series. For LN, 16 publications met the inclusion/exclusion criteria: eight randomized trials, three open label prospective clinical trials, five observational/cohort studies. For APS, no publications met the inclusion criteria. The study with the highest evidence was an RCT comparing belimumab vs. placebo, including 93 JSLE patients. Whilst the primary-endpoint was not met, a significantly higher proportion of belimumab-treated patients met the PRINTO/ACR cSLE response to therapy criteria. New evidence specifically addressing each SHARE recommendation remains limited. Conclusion Since the original SHARE literature searches, undertaken &gt;10-years ago, the main advance in JSLE treatment evidence relates to belimumab. Additional studies are urgently needed to test new/existing agents, and assess their long-term safety profile in JSLE, to facilitate evidence-based practice." @default.
• W4224142777 created "2022-04-20" @default.
• W4224142777 creator A5041204910 @default.
• W4224142777 creator A5044047186 @default.
• W4224142777 creator A5060331207 @default.
• W4224142777 creator A5084573556 @default.
• W4224142777 date "2022-04-14" @default.
• W4224142777 modified "2023-09-25" @default.
• W4224142777 title "What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012?" @default.
• W4224142777 cites W1688265474 @default.
• W4224142777 cites W1963756694 @default.
• W4224142777 cites W1968634262 @default.
• W4224142777 cites W1989273660 @default.
• W4224142777 cites W1989374335 @default.
• W4224142777 cites W1995307078 @default.
• W4224142777 cites W2001654000 @default.
• W4224142777 cites W2010623154 @default.
• W4224142777 cites W2013482837 @default.
• W4224142777 cites W2014132049 @default.
• W4224142777 cites W2018100489 @default.
• W4224142777 cites W2024442997 @default.
• W4224142777 cites W2032162517 @default.
• W4224142777 cites W2034233121 @default.
• W4224142777 cites W2040668655 @default.
• W4224142777 cites W2045209518 @default.
• W4224142777 cites W2045992760 @default.
• W4224142777 cites W2048443380 @default.
• W4224142777 cites W2049006925 @default.
• W4224142777 cites W2051573899 @default.
• W4224142777 cites W2054918860 @default.
• W4224142777 cites W2068265433 @default.
• W4224142777 cites W2073246129 @default.
• W4224142777 cites W2075595968 @default.
• W4224142777 cites W2082428789 @default.
• W4224142777 cites W2095161148 @default.
• W4224142777 cites W2096194879 @default.
• W4224142777 cites W2096286605 @default.
• W4224142777 cites W2099430274 @default.
• W4224142777 cites W2104227037 @default.
• W4224142777 cites W2105213043 @default.
• W4224142777 cites W2106848258 @default.
• W4224142777 cites W2107358534 @default.
• W4224142777 cites W2119296184 @default.
• W4224142777 cites W2119321822 @default.
• W4224142777 cites W2119837784 @default.
• W4224142777 cites W2126031441 @default.
• W4224142777 cites W2132691514 @default.
• W4224142777 cites W2141044946 @default.
• W4224142777 cites W2148843297 @default.
• W4224142777 cites W2154180283 @default.
• W4224142777 cites W2157239580 @default.
• W4224142777 cites W2171687847 @default.
• W4224142777 cites W2195635340 @default.
• W4224142777 cites W2290560590 @default.
• W4224142777 cites W2325870812 @default.
• W4224142777 cites W2347015898 @default.
• W4224142777 cites W2464135343 @default.
• W4224142777 cites W2528538343 @default.
• W4224142777 cites W2572944719 @default.
• W4224142777 cites W2575131381 @default.
• W4224142777 cites W2586917330 @default.
• W4224142777 cites W2594454279 @default.
• W4224142777 cites W2611413478 @default.
• W4224142777 cites W2611543513 @default.
• W4224142777 cites W2704261773 @default.
• W4224142777 cites W2742746034 @default.
• W4224142777 cites W2751453946 @default.
• W4224142777 cites W2757418233 @default.
• W4224142777 cites W2770998999 @default.
• W4224142777 cites W2783219594 @default.
• W4224142777 cites W2788009761 @default.
• W4224142777 cites W2791656321 @default.
• W4224142777 cites W2797862713 @default.
• W4224142777 cites W2799805513 @default.
• W4224142777 cites W2862307131 @default.
• W4224142777 cites W2889151930 @default.
• W4224142777 cites W2897882881 @default.
• W4224142777 cites W2903197412 @default.
• W4224142777 cites W2922158322 @default.
• W4224142777 cites W2922449768 @default.
• W4224142777 cites W2927871970 @default.
• W4224142777 cites W2939676820 @default.
• W4224142777 cites W2954006121 @default.
• W4224142777 cites W2987911100 @default.
• W4224142777 cites W3004033164 @default.
• W4224142777 cites W3041234419 @default.
• W4224142777 cites W3044322808 @default.
• W4224142777 cites W3130763932 @default.
• W4224142777 cites W4200617546 @default.
• W4224142777 cites W4246722364 @default.
• W4224142777 doi "https://doi.org/10.3389/fped.2022.884634" @default.
• W4224142777 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35498799" @default.
• W4224142777 hasPublicationYear "2022" @default.
• W4224142777 type Work @default.
• W4224142777 citedByCount "3" @default.
• W4224142777 countsByYear W42241427772022 @default.
• W4224142777 countsByYear W42241427772023 @default.
• W4224142777 crossrefType "journal-article" @default.
• W4224142777 hasAuthorship W4224142777A5041204910 @default.
• W4224142777 hasAuthorship W4224142777A5044047186 @default.

• next